Pharmaceutical giant GlaxoSmithKline is investing heavily in harnessing data and artificial intelligence for early-stage drug discovery, with a goal of hiring about 100 people this year to work on the effort, according to a company representative.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,